Mt. Sinai Cancer Center

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy	Body Weight, Body Weight Changes, Cachexia, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Thinness, Weight Loss, colonic disorder, colorectal neoplasm, digestive system disorder, digestive system neoplasm, endocrine system disorder, intestinal disorder, malignant endocrine neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm, rectal disorder	Recruiting	Phase 2	2026-07-15		NCT06937177

Clinical trials